Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
American Resources Corporation - Class A Common Stock
Caseys General Stores, Inc. - Common Stock
Deepmarkit Corp
Fidelity MSCI Consumer Discretionary Index ETF
Fujitsu Ltd ADR
Taiga Gold Corp
Tesco Plc New
Themes Cybersecurity ETF
Western Copper and Gold Corporation Common Stock
Xunlei Limited - American Depositary Shares
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pear Therapeutics, Inc. - Class A Common Stock
(NQ:
PEAR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pear Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022
June 08, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
95 Biggest Movers From Yesterday
↗
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge
↗
June 06, 2022
U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 06, 2022
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
↗
June 06, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.
Via
Benzinga
Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months
June 06, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 16, 2022
↗
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
↗
June 06, 2022
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Via
Benzinga
Pear Therapeutics to Participate in the Jefferies Healthcare Conference
June 02, 2022
From
Pear Therapeutics, Inc
Via
Business Wire
69 Biggest Movers From Friday
↗
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting
May 24, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022
May 19, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Chardan Capital Maintains Buy Rating for Pear Therapeutics: Here's What You Need To Know
↗
May 17, 2022
Chardan Capital has decided to maintain its Buy rating of Pear Therapeutics (NASDAQ:PEAR) and lower its price target from $16.00 to $13.00. Shares of Pear Therapeutics are trading up 9.75% over the...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
May 17, 2022
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday.
Via
Benzinga
Pear Therapeutics Reports First Quarter 2022 Financial Results
May 16, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
90 Biggest Movers From Yesterday
↗
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
↗
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative
May 12, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 11, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 11, 2022
Via
Benzinga
Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference
May 11, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference
May 03, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
90 Biggest Movers From Yesterday
↗
May 10, 2022
Gainers
Via
Benzinga
Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022
May 02, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit
April 18, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain
April 13, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in Upcoming Investor Conferences
April 05, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics Announces Program to Bring Prescription Digital Therapeutics to Patients in Recovery Through a Telehealth Provider Experience
April 04, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in Upcoming Investor Event Hosted by Credit Suisse
March 31, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
51 Biggest Movers From Yesterday
↗
March 31, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
